The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2020

Filed:

Nov. 19, 2018
Applicant:

Genesis Technologies Limited, Warrens, St. Michael, BB;

Inventors:

Jan-Eric Ahlfors, Laval, CA;

Rouwayda El-Ayoubi, Laval, CA;

Assignee:

Genesis Technologies Limited, Warrens, St. Michael, BB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/0775 (2010.01); C12N 5/0797 (2010.01); C12N 5/079 (2010.01); C12N 5/074 (2010.01); A61K 35/30 (2015.01); C12N 5/0789 (2010.01); C12N 5/077 (2010.01); C12N 5/0793 (2010.01); C12N 5/071 (2010.01); A61K 35/545 (2015.01);
U.S. Cl.
CPC ...
C12N 5/0662 (2013.01); A61K 35/30 (2013.01); C12N 5/0618 (2013.01); C12N 5/0619 (2013.01); C12N 5/0623 (2013.01); C12N 5/0647 (2013.01); C12N 5/0656 (2013.01); C12N 5/0657 (2013.01); C12N 5/0667 (2013.01); C12N 5/0668 (2013.01); C12N 5/0696 (2013.01); A61K 35/545 (2013.01); C12N 5/0676 (2013.01); C12N 2500/25 (2013.01); C12N 2501/06 (2013.01); C12N 2501/065 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/13 (2013.01); C12N 2501/155 (2013.01); C12N 2501/16 (2013.01); C12N 2501/395 (2013.01); C12N 2501/60 (2013.01); C12N 2501/602 (2013.01); C12N 2501/604 (2013.01); C12N 2501/727 (2013.01); C12N 2501/998 (2013.01); C12N 2506/094 (2013.01); C12N 2506/11 (2013.01); C12N 2506/1307 (2013.01); C12N 2506/1346 (2013.01); C12N 2506/1384 (2013.01); C12N 2510/00 (2013.01);
Abstract

A method of obtaining a neural multipotent, unipotent or somatic cell, including: i) providing a cell of a first type which is not a neural multipotent, unipotent or somatic cell; ii) increasing expression of at least one neural multipotent or unipotent gene regulator in the cell of a first type, to a level at which the at least one neural multipotent or unipotent gene regulator is capable of driving transformation of the cell of a first type into the neural multipotent, unipotent or somatic cell, wherein the at least one multipotent or unipotent gene regulator is Musashi1 (Msi1), Neurogenin 2 (Ngn2), or both Msi1 and Ngn2; and iii) placing or maintaining the cell in a neural cell culture medium and maintaining sufficient intracellular levels of the at least one multipotent or unipotent gene regulator for a sufficient period of time to allow a stable neural multipotent, unipotent or somatic cell to be obtained.


Find Patent Forward Citations

Loading…